ESMO 2026 trial results & KOL discussion, by trial →
Results slides from ESMO 2026 (Madrid, October 23–27), posted since the October 22 embargo lift: 1732 slide posts and 368 KOL infographics from 378 accounts, now on one page per tumor type, each organized by clinical trial with verbatim OCR text, trial and KOL filters, and links to KOL Pulse trial pages. Updated October 29, 2026. ← Back to the full ESMO 2026 coverage
Trials in this slide library that have a full KOL Pulse trial page (data, sources and KOL voices). Every ESMO 2026 post grouped by trial is on the ESMO 2026 trial results page →
ADC slides: Breast Cancer 165 · Lung Cancer 125 · GU Cancer 149 · GI Cancer 44 · Melanoma 3 · Gyn Cancer 27 · Heme & Other 36 (antibody-drug conjugate slides; opens the tumor page with the ADC filter on)
Create a free account, pick the tumor types you cover, and go beyond the tweet — the intelligence pharma teams use to map influence and prepare for engagement:
Summary graphics physicians, media and companies designed themselves sit in a compact section at the end of each tumor page: Breast Cancer 48 · Lung Cancer 91 · GU Cancer 61 · GI Cancer 62 · Melanoma 27 · Gyn Cancer 25 · Heme & Other 54.
A gallery of the 1732 results slide posts and 368 KOL-made infographics that oncologists, societies, media and companies posted on X from the ESMO 2026 embargo lift (October 22) through the congress in Madrid (October 23–27), compiled by KOL Pulse. It is split into one page per tumor type so each page loads quickly on a phone; every card keeps the author's full text, a link to the original post and a verbatim OCR transcription of the slide.
Breast Cancer (294 slide posts): https://kolpulse.com/kol-pulse-esmo26-slides-breast; Lung Cancer (420 slide posts): https://kolpulse.com/kol-pulse-esmo26-slides-lung; GU Cancer (453 slide posts): https://kolpulse.com/kol-pulse-esmo26-slides-gu; GI Cancer (254 slide posts): https://kolpulse.com/kol-pulse-esmo26-slides-gi; Melanoma (62 slide posts): https://kolpulse.com/kol-pulse-esmo26-slides-melanoma; Gyn Cancer (35 slide posts): https://kolpulse.com/kol-pulse-esmo26-slides-gyn; Heme & Other (214 slide posts): https://kolpulse.com/kol-pulse-esmo26-slides-other.
Each page groups slides by clinical trial, with links to the trial's KOL Pulse trial page and its discussion on the ESMO 2026 conference page. Cross-trial comparisons and slides not tied to a tracked trial come last, physician posts come first, and KOL-made infographics sit in a compact section after the slides. Filters by trial and KOL are on every page.
Everything posted before the October 22 embargo lift, including previews, watchlists and top-10 lists, is in the ESMO 2026 pre-congress slide archive: https://kolpulse.com/kol-pulse-esmo26-slides-archive
Yes. Paste a tumor page URL, or a filtered link, into your assistant and ask questions against it. Example prompt: "From the slide transcriptions on this page, list each trial's primary endpoint result with the hazard ratio and data cut exactly as printed on the slide, and the physician who posted it."